Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Frequently asked questions
What sector does Champions Oncology, Inc (CSBR) operate in?
Champions Oncology, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Champions Oncology, Inc (CSBR) current stock price?
As of the latest data, Champions Oncology, Inc stock price is $4.95, with a previous close of $4.99. Champions Oncology, Inc lost -$0.04 in the last trading session, representing a -0.8% loss.
What is Champions Oncology, Inc (CSBR) current market capitalization?
Champions Oncology, Inc market cap is approximately 68.77 million.
What is Champions Oncology, Inc (CSBR) Earnings Per Share (EPS)?
The trailing EPS is -$0.08, and the forward EPS is $0.10.
What is Champions Oncology, Inc (CSBR) EBITDA?
Champions Oncology, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -174.00 thousand.
Does Champions Oncology, Inc (CSBR) pay dividends?
No. Champions Oncology, Inc does not pay a dividend.
When is Champions Oncology, Inc (CSBR) next earnings report?
Champions Oncology, Inc is expected to release its next earnings report on July 31, 2026.
What is Champions Oncology, Inc (CSBR) beta (volatility) score?
Champions Oncology, Inc has a beta of 0.412, indicating lower volatility than the overall market.
